Zydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...

The early results from the IMAGINE study were based on the first 10 patients of the planned 24 patients to be enrolled.Both adult and child...

Sir David Jason talked about their friendship but also disclosed that they have lost touch in recent years.

As per the agreement, Laurus will acquire 26.62% stake (fully diluted basis) for a cash consideration of approximately Rs 46 crores, subjec...

Sources said Justice Lodha filed a complaint with the Malviya Nagar police on May 31.

The isolation of L-asparaginase containing fungi can lead to development of new chemotherapeutic treatment methods.

Buy Aurobindo Pharma at a price target of Rs 920.

Washington, Nov 21 (IANS) A group of American scientists has found a new possibility to cure leukemia, a deadly disease that strikes patien...

According to a statement issued by the city-based drug maker, its generic version of the injection is available in single-dose, 20 ml flint...

The U.S. Food and Drug Administration on Wednesday approved a radical new one-time treatment from the Swiss drugmaker, weeks earlier than e...

New York, Sep 29 (IANS) Breast-feeding not only protects babies from premature deaths and serious diseases but also mothers from breast can...

When Dr. Lukas Wartman began medical school at Washington University in St. Louis, he knew he wanted to study cancer and treat patients.

Drug firm Zydus Cadila has received tentative nod from the US health regulator to market Clofarabine injection, used for treatment of cancer

Amgen, the world's largest biotechnology company, agreed to buy Micromet in a $1.16 billion deal to gain an experimental leukemia drug.